Kevin I. Duan

554 total citations
32 papers, 376 citations indexed

About

Kevin I. Duan is a scholar working on Pulmonary and Respiratory Medicine, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Kevin I. Duan has authored 32 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 8 papers in General Health Professions and 7 papers in Economics and Econometrics. Recurrent topics in Kevin I. Duan's work include Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Respiratory Support and Mechanisms (5 papers) and Healthcare Policy and Management (5 papers). Kevin I. Duan is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Respiratory Support and Mechanisms (5 papers) and Healthcare Policy and Management (5 papers). Kevin I. Duan collaborates with scholars based in United States, Canada and Australia. Kevin I. Duan's co-authors include Maoyin Pang, Lisa Longato, Jack R. Wands, Suzanne M. de la Monte, Ming Tong, Laura C. Feemster, Laura J. Spece, David H. Au, Jiman He and Maxwell Birger and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Kevin I. Duan

23 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin I. Duan United States 10 131 91 82 70 65 32 376
Satyajeet Roy United States 13 67 0.5× 48 0.5× 43 0.5× 47 0.7× 78 1.2× 42 433
Fa‐Bao Hao China 13 195 1.5× 61 0.7× 83 1.0× 77 1.1× 137 2.1× 24 675
Mark Rutkowski United States 14 37 0.3× 103 1.1× 87 1.1× 109 1.6× 90 1.4× 18 561
Caner Çavdar Türkiye 14 69 0.5× 31 0.3× 67 0.8× 77 1.1× 52 0.8× 64 546
Habeeb Salameh United States 11 412 3.1× 146 1.6× 96 1.2× 68 1.0× 114 1.8× 21 784
Nirmal Baral Nepal 15 132 1.0× 51 0.6× 49 0.6× 53 0.8× 320 4.9× 48 759
S. Sonkodi Hungary 14 148 1.1× 27 0.3× 51 0.6× 62 0.9× 70 1.1× 66 662
Sanjay D’Cruz India 15 76 0.6× 16 0.2× 137 1.7× 73 1.0× 28 0.4× 63 650
Manuel Heras Spain 14 64 0.5× 24 0.3× 71 0.9× 42 0.6× 65 1.0× 80 514

Countries citing papers authored by Kevin I. Duan

Since Specialization
Citations

This map shows the geographic impact of Kevin I. Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin I. Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin I. Duan more than expected).

Fields of papers citing papers by Kevin I. Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin I. Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin I. Duan. The network helps show where Kevin I. Duan may publish in the future.

Co-authorship network of co-authors of Kevin I. Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin I. Duan. A scholar is included among the top collaborators of Kevin I. Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin I. Duan. Kevin I. Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spece, Laura J., Kevin I. Duan, Brian N. Palen, et al.. (2025). Incidence and Predictors of Long-Term Hypnotic Receipt among Patients with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 22(6). 863–871.
2.
3.
Duan, Kevin I., Anirban Basu, Brad Wright, et al.. (2024). Association of Observation Stays with Clinical Outcomes and Costs in Medicare: An Instrumental Variable Analysis. Journal of General Internal Medicine. 40(7). 1590–1598.
4.
Spece, Laura J., Lucas M. Donovan, Kevin I. Duan, et al.. (2024). The Impact of Changing Race-Specific Equations for Lung Function Tests among Veterans with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 21(9). 1272–1280. 3 indexed citations
5.
Duan, Kevin I., et al.. (2024). Benefit–Harm Analysis of Earlier Initiation of Triple Therapy for Prevention of Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 21(8). 1139–1146. 1 indexed citations
6.
Duan, Kevin I., Lucas M. Donovan, Laura J. Spece, et al.. (2023). Inhaler Formulary Change in COPD and the Association with Exacerbations, Health Care Utilization, and Costs. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 11(1). 37–46. 2 indexed citations
7.
Donovan, Lucas M., Nancy H. Stewart, Laura J. Spece, et al.. (2023). Assessment of Obstructive Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease in Primary Care. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 11(2). 136–143. 1 indexed citations
8.
Donovan, Lucas M., Laura J. Spece, Kevin I. Duan, et al.. (2023). Sleep Testing and Mortality in a Propensity-matched Cohort of Patients with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 20(11). 1642–1653. 1 indexed citations
9.
Duan, Kevin I., Lucas M. Donovan, Laura J. Spece, et al.. (2023). Trends and Rural–Urban Differences in the Initial Prescription of Low-Value Inhaled Corticosteroids among U.S. Veterans with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 20(5). 668–676. 5 indexed citations
10.
Spece, Laura J., Kevin I. Duan, Brian N. Palen, et al.. (2023). Risks of Zolpidem among Patients with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 21(1). 68–75.
11.
Coley, R. Yates, Kevin I. Duan, Andrea J. Hoopes, et al.. (2022). A call to integrate health equity into learning health system research training. Learning Health Systems. 6(4). e10330–e10330. 17 indexed citations
12.
Donovan, Lucas M., Catherine McCall, Rahul K. Sharma, et al.. (2022). Impact of mail-based continuous positive airway pressure initiation on treatment usage and effectiveness. Sleep And Breathing. 27(1). 303–308.
13.
Duan, Kevin I., Hugo Flores, Daniel Palazuelos, et al.. (2021). Economic evaluation of a novel community-based diabetes care model in rural Mexico: a cost and cost-effectiveness study. BMJ Open. 11(4). e046826–e046826. 3 indexed citations
14.
Duan, Kevin I., et al.. (2021). Cost analysis of a coaching intervention to increase use of transradial percutaneous coronary intervention. SHILAP Revista de lepidopterología. 2(1). 123–123. 2 indexed citations
15.
Cobb, Natalie, Kevin I. Duan, Kevin P. Seitz, et al.. (2020). Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID-19 versus Influenza. Annals of the American Thoracic Society. 18(4). 632–640. 69 indexed citations
16.
Duan, Kevin I., Laura J. Spece, Edwin S. Wong, et al.. (2020). Low-Value Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease and the Association with Healthcare Utilization and Costs. Annals of the American Thoracic Society. 18(6). 989–996. 2 indexed citations
17.
Spece, Laura J., Kevin I. Duan, Lucas M. Donovan, et al.. (2020). Reassessment of Home Oxygen Prescription after Hospitalization for Chronic Obstructive Pulmonary Disease. A Potential Target for Deimplementation. Annals of the American Thoracic Society. 18(3). 426–432. 13 indexed citations
18.
Makaroun, Lena K., et al.. (2017). Specialty Care Access in the Safety Net—the Role of Public Hospitals and Health Systems. Journal of Health Care for the Poor and Underserved. 28(1). 566–581. 9 indexed citations
19.
Monte, Suzanne M. de la, Maoyin Pang, Kevin I. Duan, et al.. (2011). Peroxisome proliferator‐activated receptor agonist treatment of alcohol‐induced hepatic insulin resistance. Hepatology Research. 41(4). 386–398. 34 indexed citations
20.
Pang, Maoyin, Suzanne M. de la Monte, Lisa Longato, et al.. (2009). PPARδ agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair. Journal of Hepatology. 50(6). 1192–1201. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026